Drug resistance may arise from various molecular mechanisms, such as abnormal activation of the epidermal growth factor receptor (EGFR) signaling cascade (16–18), dysregulation of the PI3K/AKT/mTOR pathway (19–21), and the role of immunosuppressive cells in the tumor microenvironment (TME) (22). This evidence concerns the gene EGFR and neoplasm.